✦ LIBER ✦

Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial

✍ Scribed by G.G. Krueger; R.G. Langley; A.Y. Finlay; C.E.M. Griffiths; J.M. Woolley; D. Lalla; A. Jahreis

Book ID: 108668510
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 199 KB
Volume: 153
Category: Article
ISSN: 0007-0963
DOI: 10.1111/j.1365-2133.2005.06948.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Decitabine improves patient outcomes in

Decitabine improves patient outcomes in myelodysplastic syndromes : Results of a phase III randomized study

✍ Hagop Kantarjian; Jean-Pierre J. Issa; Craig S. Rosenfeld; John M. Bennett; Mahe 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB

## Abstract ## BACKGROUND Aberrant DNA methylation, which results in leukemogenesis, is frequent in patients with myelodysplastic syndromes (MDS) and is a potential target for pharmacologic therapy. Decitabine indirectly depletes methylcytosine and causes hypomethylation of target gene promoters.

A global phase III randomized controlled

A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction

✍ K.A. Papp; S. Tyring; M. Lahfa; J. Prinz; C.E.M. Griffiths; A.M. Nakanishi; R. Z 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 256 KB

Clinical Efficacy of Efalizumab in Patie

Clinical Efficacy of Efalizumab in Patients With Chronic Plaque Psoriasis: Results From Three Randomized Placebo-Controlled Phase III Trials: Part I

✍ David M. Pariser; Kenneth B. Gordon; Kim A. Papp; Craig L. Leonardi; Paul Kwon; 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 201 KB

Impact of adalimumab treatment on health

Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis

✍ D. Revicki; M.K. Willian; J.-H. Saurat; K.A. Papp; J.-P. Ortonne; C. Sexton; A. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB

CLinical experience acquired with the ef

CLinical experience acquired with the efalizumab (Raptiva®) (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from a phase III international randomized, placebo-controlled trial

✍ L. Dubertret; W. Sterry; J.D. Bos; S. Chimenti; S. Shumack; C.G. Larsen; N.H. Sh 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 342 KB

Improvement in quality of life with infl

Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial

✍ K. Reich; F.O. Nestle; K. Papp; J.-P. Ortonne; Y. Wu; M. Bala; R. Evans; C. Guzz 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB